Search results
Results from the WOW.Com Content Network
[12] [13] Studies conflict on the prevalence of depression in the elderly, but most data suggest there is a reduction in this age group. [14] Depressive disorders are more common in urban than in rural populations and, in general, the prevalence is higher in groups with adverse socio-economic factors (for example in homeless people). [15]
What links here; Upload file; Special pages; Printable version; Page information
Research suggests that the prevalence of children with major depressive disorder in Western cultures ranges from 1.9% to 3.4% among primary school children. [9] Among teenagers, up to 9% meet criteria for depression at a given moment and approximately 20% experience depression sometime during adolescence. [10]
The first published figures on the 14 country surveys completed to date, indicate that, of those disorders assessed, anxiety disorders are the most common in all but 1 country (prevalence in the prior 12-month period of 2.4% to 18.2%) and mood disorders next most common in all but 2 countries (12-month prevalence of 0.8% to 9.6%), while ...
The United States of America includes the insular areas. The Netherlands includes Aruba and the Netherlands Antilles. Denmark includes Greenland and the Faroe islands. China includes the SARs of Hong Kong and Macao. Date: 11 January 2010: Source: Vector map from BlankMap-World6, compact.svg by Canuckguy et al.
What links here; Related changes; Upload file; Special pages; Permanent link
The United States of America includes the insular areas. The Netherlands includes Aruba and the Netherlands Antilles. Denmark includes Greenland and the Faroe islands. Date: 24 July 2016: Source: Data from World Health Organization Estimated Deaths 2012 Vector map from BlankMap-World6, compact.svg by Canuckguy et al. Author: Chris55
The Center for Epidemiologic Studies Depression Scale for Children (CES-DC) is a modified version of the Center for Epidemiologic Studies Depression Scale. This measure assesses both depressive symptoms as well as symptom improvement in a wide range of children and adolescents, ages 6–17. [ 3 ]